Reduced Oxidative Phosphorylation and Increased Glycolysis in Human Glaucoma Lamina Cribrosa Cells.
Adenosine Triphosphate
/ metabolism
Aminohydrolases
/ genetics
Biomarkers
Blotting, Western
Cells, Cultured
Gene Expression Profiling
Glaucoma, Open-Angle
/ metabolism
Glial Fibrillary Acidic Protein
/ metabolism
Glutaminase
/ genetics
Glycolysis
/ physiology
Humans
Methylenetetrahydrofolate Dehydrogenase (NADP)
/ genetics
Mitochondrial Diseases
/ metabolism
Monocarboxylic Acid Transporters
/ genetics
Multifunctional Enzymes
/ genetics
Muscle Proteins
/ genetics
Optic Disk
/ metabolism
Optic Nerve Diseases
/ metabolism
Oxidative Phosphorylation
Oxygen Consumption
/ physiology
RNA, Messenger
/ genetics
Real-Time Polymerase Chain Reaction
Symporters
/ genetics
Tissue Donors
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
02 11 2020
02 11 2020
Historique:
entrez:
2
11
2020
pubmed:
3
11
2020
medline:
8
5
2021
Statut:
ppublish
Résumé
The lamina cribrosa (LC) is a key site of damage in glaucomatous optic neuropathy. We previously found that glaucoma LC cells have an increased profibrotic gene expression, with mitochondrial dysfunction in the form of decreased mitochondrial membrane potential. Altered cell bioenergetics have recently been reported in organ fibrosis and in cancer. In this study, we carried out a systematic mitochondrial bioenergetic assessment and measured markers of alternative sources of cellular energy in normal and glaucoma LC cells. LC cells from three glaucoma donors and three age-matched normal controls were assessed using VICTOR X4 Perkin Elmer (Waltham, MA) plate reader with different phosphorescent and luminescent probes. adenosine triphosphate levels, oxygen consumption rate, and extracellular acidification were measured and normalized to total protein content. RNA and protein expression levels of MCT1, MCT4, MTFHD2, and GLS2 were quantified using real-time RT-PCR and Western blotting. Glaucoma LC cells contain significantly less adenosine triphosphate (P < .05) when supplied with either glucose or galactose. They also showed significantly diminished oxygen consumption in both basal and maximal respiration with more lactic acid contribution in ECA. Both mRNA and protein expression levels of MCT1, MCT4, MTHFD2, and GLS2 were significantly increased in glaucoma LC cells. We demonstrate evidence of metabolic reprogramming (The Warburg effect) in glaucoma LC cells. Expression of markers of glycolysis, glutamine, and one carbon metabolism are elevated in glaucoma cells at both the mRNA and protein levels. A better understanding of bioenergetics in glaucoma may help in the development of new therapeutics.
Identifiants
pubmed: 33137197
pii: 2771917
doi: 10.1167/iovs.61.13.4
pmc: PMC7645202
doi:
Substances chimiques
Biomarkers
0
GFAP protein, human
0
Glial Fibrillary Acidic Protein
0
MTHFD2 protein, human
0
Monocarboxylic Acid Transporters
0
Multifunctional Enzymes
0
Muscle Proteins
0
RNA, Messenger
0
SLC16A4 protein, human
0
Symporters
0
monocarboxylate transport protein 1
0
Adenosine Triphosphate
8L70Q75FXE
Methylenetetrahydrofolate Dehydrogenase (NADP)
EC 1.5.1.5
GLS2 protein, human
EC 3.5.1.2
Glutaminase
EC 3.5.1.2
Aminohydrolases
EC 3.5.4.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4Commentaires et corrections
Type : ErratumIn
Références
PLoS One. 2015 Oct 23;10(10):e0140919
pubmed: 26496696
Cell Cycle. 2009 Dec;8(23):3984-4001
pubmed: 19923890
Nat Chem Biol. 2005 Dec;1(7):371-6
pubmed: 16370372
IUBMB Life. 2012 Jan;64(1):1-9
pubmed: 22131303
J Clin Invest. 2017 Feb 1;127(2):405-414
pubmed: 28145905
Free Radic Biol Med. 2017 May;106:184-195
pubmed: 28189850
Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4912-22
pubmed: 18614807
Free Radic Biol Med. 2011 Nov 1;51(9):1621-35
pubmed: 21872656
Am J Ophthalmol. 1990 Feb 15;109(2):180-8
pubmed: 2405683
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
J Neuroinflammation. 2018 Nov 13;15(1):313
pubmed: 30424795
Am J Ophthalmol. 1983 May;95(5):673-91
pubmed: 6846459
Cell Cycle. 2011 Aug 1;10(15):2504-20
pubmed: 21778829
Invest Ophthalmol Vis Sci. 2009 Feb;50(2):707-16
pubmed: 18936150
J Neurochem. 2005 Jul;94(1):1-14
pubmed: 15953344
Cell Cycle. 2016 Jun 17;15(12):1643-52
pubmed: 27229292
J Biol Chem. 2005 Jul 22;280(29):27213-21
pubmed: 15917240
Laryngoscope. 2017 Mar;127(3):E107-E113
pubmed: 27585358
Annu Rev Nutr. 1995;15:133-59
pubmed: 8527215
Am J Respir Crit Care Med. 2012 Oct 15;186(8):740-51
pubmed: 22923663
Nat Commun. 2014;5:3128
pubmed: 24451681
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Prog Retin Eye Res. 2017 Jul;59:1-52
pubmed: 28300644
Biochim Biophys Acta. 2009 Jan;1793(1):154-70
pubmed: 18694785
Mitochondrion. 2017 Jul;35:44-53
pubmed: 28499981
Exp Eye Res. 2011 Aug;93(2):204-12
pubmed: 20691180
Physiol Res. 2015;64(4):513-22
pubmed: 25470525
Annu Rev Cell Dev Biol. 2011;27:441-64
pubmed: 21985671
Biomed Res Int. 2015;2015:242437
pubmed: 26779534
Oncogene. 2010 Jul 8;29(27):3964-76
pubmed: 20453889
Mol Cancer Res. 2015 Oct;13(10):1361-6
pubmed: 26101208
Nat Cell Biol. 2011 Feb;13(2):132-41
pubmed: 21258367
Mol Vis. 2005 Sep 23;11:798-810
pubmed: 16205625
Exp Eye Res. 2020 Apr;193:107980
pubmed: 32088241
Mol Vis. 2009;15:76-88
pubmed: 19145252
Laryngoscope. 2020 Jan 6;:
pubmed: 31904876
Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):5046-5052
pubmed: 27661856
Cell Chem Biol. 2019 Sep 19;26(9):1197-1199
pubmed: 31539503
Pflugers Arch. 2004 Feb;447(5):619-28
pubmed: 12739169
Invest Ophthalmol Vis Sci. 2012 Apr 30;53(4):2431-7
pubmed: 22427588
Invest Ophthalmol Vis Sci. 2018 Feb 1;59(2):831-842
pubmed: 29411011
Eur Cell Mater. 2018 Oct 18;36:171-183
pubmed: 30334244
Biosci Rep. 2012 Dec;32(6):587-95
pubmed: 22943412
Cell Death Differ. 2015 Apr;22(4):612-25
pubmed: 25257176
PLoS One. 2016 Jan 11;11(1):e0146654
pubmed: 26752072
Brain. 2018 Jul 1;141(7):1963-1980
pubmed: 29931057
Am J Physiol Lung Cell Mol Physiol. 2017 Dec 1;313(6):L1164-L1173
pubmed: 28860144
Commun Integr Biol. 2018 Jan 19;11(1):e1356956
pubmed: 29497468
Neurobiol Dis. 2015 Oct;82:78-85
pubmed: 26054436
Oncotarget. 2014 May 15;5(9):2635-47
pubmed: 24797434
J Clin Invest. 2013 Sep;123(9):3678-84
pubmed: 23999442
BMC Ophthalmol. 2014 Dec 02;14:153
pubmed: 25444463
Cancer Res. 2012 Oct 1;72(19):5130-40
pubmed: 22850421
J Biol Chem. 2012 Aug 24;287(35):29516-28
pubmed: 22761433
Biol Chem. 2012 Dec;393(12):1485-1512
pubmed: 23092819
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2315-23
pubmed: 11527945
J Glaucoma. 2009 Feb;18(2):93-100
pubmed: 19225343
Invest Ophthalmol Vis Sci. 2014 Apr 08;55(5):3127-39
pubmed: 24713487
Prog Retin Eye Res. 2017 May;58:89-114
pubmed: 28223208
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6489-6499
pubmed: 29288267
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Methods Mol Biol. 2015;1265:333-48
pubmed: 25634285
Hematol Oncol Clin North Am. 2012 Jun;26(3):629-48, ix
pubmed: 22520983
Mol Vis. 2011;17:1182-91
pubmed: 21617752
Vitam Horm. 2008;79:393-410
pubmed: 18804703
Annu Rev Pathol. 2010;5:297-348
pubmed: 20078222
Science. 1956 Aug 10;124(3215):269-70
pubmed: 13351639
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7455-60
pubmed: 20378837
Histol Histopathol. 2018 Oct;33(10):1075-1087
pubmed: 29809274
Hum Mol Genet. 2010 Oct 1;19(19):3844-51
pubmed: 20660115